MAX-40279 structure
|
Common Name | MAX-40279 | ||
|---|---|---|---|---|
| CAS Number | 2070931-57-4 | Molecular Weight | 438.52 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H23FN6OS | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of MAX-40279MAX-40279 is a dual and potent inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 has the potential for the research of acute myelogenous leukemia (AML) (extracted from patent WO2021180032)[1]. |
| Name | MAX-40279 |
|---|
| Description | MAX-40279 is a dual and potent inhibitor of FLT3 kinase and FGFR kinase. MAX-40279 has the potential for the research of acute myelogenous leukemia (AML) (extracted from patent WO2021180032)[1]. |
|---|---|
| Related Catalog | |
| Target |
FLT3 and FGFR[1] |
| References |
[1]. Yuguang Wang, et al. Novel Therapeutic Methods. Patent WO2021180032A1. |
| Molecular Formula | C22H23FN6OS |
|---|---|
| Molecular Weight | 438.52 |
| InChIKey | AVIOBQFPAGEICQ-UHFFFAOYSA-N |
| SMILES | COc1cc(F)ccc1-c1c(C)sc2cnc(Nc3cnn(C4CCNCC4)c3)nc12 |
| Storage condition | -20°C |